Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Febuxostat for Hyperuricemia in Hemodialysis Patients
NCT03149939Completed
- Sponsor
- Benha University
- Start
- Jan 2017
- Primary completion
- Apr 2017
- Modality
- Small Molecules
01
Overview
Open-label, single-arm trial of febuxostat in hyperuricemia, sponsored by Benha University. Primary endpoint: Change in serum uric acid at 3 months. Started Jan 2017; status: completed.
02
Drugs
febuxostat
03
Conditions
hyperuricemia
Beyond the preview
Go deeper on NCT03149939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03149939.